Tolerability of monoclonal antibodies in multiple myeloma

Thomas Martin, MD, from the UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, discusses the tolerability of monoclonal antibodies. According to Prof Martin, monoclonal antibodies are well tolerated, however, at the first infusion there can be infusion-related reactions.
Recorded at the Myeloma 2016 meeting held in Boston, MA.

Share this video